# Beam Therapeutics Inc.: filings

BEAM · Nasdaq · CIK 1745999 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/beam.md) · [Financials](/companies/beam/financials.md) · [Filings](/companies/beam/filings.md) · [Insiders](/companies/beam/insiders.md)

## Reports and events: 108 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 208, 8-K 69, 144 43, SC 13G/A 24, 3 23, 10-Q 20, SCHEDULE 13G/A 16, SC 13G 12, CORRESP 10, UPLOAD 8, 10-K 7, 4/A 7, S-8 7, DEF 14A 6, DEFA14A 6, 424B5 5, ARS 4, S-1/A 4, DRSLTR 3, S-3ASR 3, 424B4 2, 424B7 2, D 2, DRS 2, EFFECT 2, S-1 2, SEC STAFF LETTER 2, 8-A12B 1, CERT 1, D/A 1, DRS/A 1, FWP 1, S-1MEF 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-04 | 11:13 ET | [10-Q](/filings/0001193125-26-331541.md) | Quarterly report, period 2026-06-30 | 0001193125-26-331541 |
| 2026-08-04 | 11:09 ET | [8-K](/filings/0001193125-26-331522.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-331522 |
| 2026-06-08 | 20:05 ET | [8-K](/filings/0001193125-26-261693.md) | 5.07 Shareholder vote results | 0001193125-26-261693 |
| 2026-05-07 | 11:22 ET | [10-Q](/filings/0001193125-26-210338.md) | Quarterly report, period 2026-03-31 | 0001193125-26-210338 |
| 2026-05-07 | 11:06 ET | [8-K](/filings/0001193125-26-210299.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-210299 |
| 2026-04-17 | 20:05 ET | [DEF 14A](/filings/0001193125-26-161512.md) | Proxy statement, period 2026-06-03 | 0001193125-26-161512 |
| 2026-03-05 | 21:05 ET | [8-K](/filings/0001193125-26-093914.md) | 1.02 Termination of a material agreement | 0001193125-26-093914 |
| 2026-02-24 | 12:10 ET | [10-K](/filings/0001193125-26-065194.md) | Annual report, period 2025-12-31 | 0001193125-26-065194 |
| 2026-02-24 | 12:05 ET | [8-K](/filings/0001193125-26-065191.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-065191 |
| 2026-02-12 | 21:05 ET | [8-K](/filings/0001193125-26-048684.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-048684 |
| 2026-02-05 | 21:05 ET | [8-K](/filings/0001193125-26-039365.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-039365 |
| 2026-01-12 | 12:00 ET | [8-K](/filings/0001193125-26-009722.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009722 |
| 2025-12-11 | 21:30 ET | [8-K](/filings/0001193125-25-316043.md) | 2.01 Completion of an acquisition or disposition | 0001193125-25-316043 |
| 2025-11-04 | 12:11 ET | [10-Q](/filings/0001193125-25-263542.md) | Quarterly report, period 2025-09-30 | 0001193125-25-263542 |
| 2025-11-04 | 12:06 ET | [8-K](/filings/0001193125-25-263536.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-263536 |
| 2025-08-05 | 11:14 ET | [10-Q](/filings/0000950170-25-102393.md) | Quarterly report, period 2025-06-30 | 0000950170-25-102393 |
| 2025-08-05 | 11:07 ET | [8-K](/filings/0000950170-25-102389.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-102389 |
| 2025-07-03 | 20:30 ET | [8-K](/filings/0000950170-25-093906.md) | 3.02 Unregistered sale of equity | 0000950170-25-093906 |
| 2025-06-06 | 20:05 ET | [8-K](/filings/0000950170-25-083043.md) | 5.07 Shareholder vote results | 0000950170-25-083043 |
| 2025-05-06 | 11:30 ET | [10-Q](/filings/0000950170-25-063966.md) | Quarterly report, period 2025-03-31 | 0000950170-25-063966 |
| 2025-05-06 | 11:05 ET | [8-K](/filings/0000950170-25-063955.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-063955 |
| 2025-04-18 | 20:00 ET | [DEF 14A](/filings/0000950170-25-055853.md) | Proxy statement, period 2025-06-04 | 0000950170-25-055853 |
| 2025-03-10 | 21:02 ET | [8-K](/filings/0001193125-25-051072.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-051072 |
| 2025-03-10 | 10:06 ET | [8-K](/filings/0001193125-25-050334.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-050334 |
| 2025-02-25 | 12:30 ET | [10-K](/filings/0000950170-25-026076.md) | Annual report, period 2024-12-31 | 0000950170-25-026076 |
| 2025-02-25 | 12:19 ET | [8-K](/filings/0000950170-25-026070.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-026070 |
| 2025-01-13 | 12:05 ET | [8-K](/filings/0000950170-25-004558.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-004558 |
| 2024-12-09 | 12:01 ET | [8-K](/filings/0001193125-24-272860.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-272860 |
| 2024-12-06 | 12:06 ET | [8-K](/filings/0001193125-24-271965.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-271965 |
| 2024-12-04 | 12:08 ET | [8-K](/filings/0001193125-24-270314.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-270314 |
| 2024-11-05 | 14:06 ET | [10-Q](/filings/0000950170-24-121104.md) | Quarterly report, period 2024-09-30 | 0000950170-24-121104 |
| 2024-11-05 | 14:00 ET | [8-K](/filings/0000950170-24-121099.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-121099 |
| 2024-11-05 | 13:30 ET | [8-K](/filings/0000950170-24-121088.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-121088 |
| 2024-11-05 | 12:05 ET | [8-K](/filings/0000950170-24-121069.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-121069 |
| 2024-08-06 | 12:55 ET | [10-Q](/filings/0000950170-24-091242.md) | Quarterly report, period 2024-06-30 | 0000950170-24-091242 |
| 2024-08-06 | 11:08 ET | [8-K](/filings/0000950170-24-091201.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-091201 |
| 2024-07-15 | 11:01 ET | [8-K](/filings/0001193125-24-178824.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-178824 |
| 2024-06-10 | 20:30 ET | [8-K](/filings/0000950170-24-071345.md) | 5.07 Shareholder vote results | 0000950170-24-071345 |
| 2024-05-07 | 11:19 ET | [10-Q](/filings/0000950170-24-053939.md) | Quarterly report, period 2024-03-31 | 0000950170-24-053939 |
| 2024-05-07 | 11:09 ET | [8-K](/filings/0000950170-24-053928.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-053928 |
| 2024-04-19 | 20:15 ET | [DEF 14A](/filings/0000950170-24-046017.md) | Proxy statement, period 2024-06-05 | 0000950170-24-046017 |
| 2024-02-27 | 12:22 ET | [10-K](/filings/0000950170-24-020622.md) | Annual report, period 2023-12-31 | 0000950170-24-020622 |
| 2024-02-27 | 11:43 ET | [8-K](/filings/0000950170-24-020608.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-020608 |
| 2024-01-08 | 11:55 ET | [8-K](/filings/0000950170-24-002673.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-002673 |
| 2023-12-14 | 21:05 ET | [8-K](/filings/0001193125-23-295457.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-295457 |
| 2023-11-08 | 12:30 ET | [10-Q](/filings/0000950170-23-060683.md) | Quarterly report, period 2023-09-30 | 0000950170-23-060683 |
| 2023-11-08 | 12:00 ET | [8-K](/filings/0000950170-23-060660.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-060660 |
| 2023-10-31 | 10:44 ET | [8-K](/filings/0000950170-23-056542.md) | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-056542 |
| 2023-10-19 | 12:50 ET | [8-K](/filings/0001193125-23-258963.md) | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-258963 |
| 2023-08-08 | 11:30 ET | [10-Q](/filings/0000950170-23-039364.md) | Quarterly report, period 2023-06-30 | 0000950170-23-039364 |

Page 1 of 3. [Older](/companies/beam/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.